Adenosine/dopamine interaction:: implications for the treatment of Parkinson's disease

被引:104
作者
Ferré, S
Popoli, P
Giménez-Llort, L
Rimondini, R
Müller, CE
Strömberg, I
Ögren, O
Fuxe, K
机构
[1] Natl Inst Drug Abuse, IRP, NIH, Baltimore, MD 21224 USA
[2] Ist Super Sanita, Dept Pharmacol, I-00161 Rome, Italy
[3] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden
[4] Univ Wurzburg, Dept Pharmaceut Chem, Inst Pharm & Food Chem, D-97074 Wurzburg, Germany
关键词
adenosine receptors; dopamine receptors; receptor/receptor interaction; Parkinson's disease; sensitization; tolerance;
D O I
10.1016/S1353-8020(00)00063-8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Evidence for a role of dopaminergic neurotransmission in the motor effects of adenosine antagonists, such as caffeine, is reviewed, based on the existence of specific antagonistic interactions between specific subtypes of adenosine and dopamine receptors in the striatum. Both adenosine A(1) and adenosine A(2A) receptor antagonists induce motor activation in rodents. At least a certain degree of dopaminergic activity is required to obtain adenosine antagonist-induced motor activation, with adenosine A(1) antagonists being the most sensitive and non-selective adenosine antagonists the most resistant to striatal dopamine depletion. When considering long-term treatment with adenosine antagonists concomitant administration of dopamine agonists might be required in order to obtain strong motor effects (cross-sensitization) and to avoid the development of telerance. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:235 / 241
页数:7
相关论文
共 70 条
[1]  
Boegman RJ, 1996, SYNAPSE, V22, P70, DOI 10.1002/(SICI)1098-2396(199601)22:1<70::AID-SYN8>3.0.CO
[2]  
2-F
[3]   Repeated co-administration of caffeine and bromocriptine prevents tolerance to the effects of caffeine in the turning behavior animal model [J].
Casas, M ;
Prat, G ;
Robledo, P ;
Barbanoj, M ;
Kulisevsky, J ;
Jané, F .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1999, 9 (06) :515-521
[4]   Adenosine A(2A) receptors modulate the binding characteristics of dopamine D-2 receptors in stably cotransfected fibroblast cells [J].
Dasgupta, S ;
Ferre, S ;
Kull, B ;
Hedlund, PB ;
Finnman, UB ;
Ahlberg, S ;
Arenas, E ;
Fredholm, BB ;
Fuxe, K .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 316 (2-3) :325-331
[5]  
Dixon AK, 1997, J NEUROCHEM, V69, P315
[6]   Motor stimulant effects of caffeine in 6-hydroxydopamine-lesioned rats are dependent on previous stimulation of dopamine receptors:: a different role of D1 and D2 receptors [J].
Fenu, S ;
Morelli, M .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1998, 10 (05) :1878-1884
[7]   Adenosine A(2A) receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats [J].
Fenu, S ;
Pinna, A ;
Ongini, E ;
Morelli, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 321 (02) :143-147
[8]   Dopamine D-1 receptor-mediated facilitation of GABAergic neurotransmission in the rat strioentopeduncular pathway and its modulation by adenosine A(1) receptor-mediated mechanisms [J].
Ferre, S ;
OConnor, WT ;
Svenningsson, P ;
Bjorklund, L ;
Lindberg, J ;
Tinner, B ;
Stromberg, I ;
Goldstein, M ;
Ogren, SO ;
Ungerstedt, U ;
Fredholm, BB ;
Fuxe, K .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1996, 8 (07) :1545-1553
[9]   DOPAMINE DENERVATION LEADS TO AN INCREASE IN THE INTRAMEMBRANE INTERACTION BETWEEN ADENOSINE-A2 AND DOPAMINE-D2 RECEPTORS IN THE NEOSTRIATUM [J].
FERRE, S ;
FUXE, K .
BRAIN RESEARCH, 1992, 594 (01) :124-130
[10]   Adenosine-dopamine interactions in the ventral striatum - Implications for the treatment of schizophrenia [J].
Ferre, S .
PSYCHOPHARMACOLOGY, 1997, 133 (02) :107-120